Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Universidad de Especialidades Espiritu Santo

ClinicalTrials.gov lists Universidad de Especialidades Espiritu Santo as lead sponsor of 10 trials.

EC Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

4 0 2012 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers Universidad de Especialidades Espiritu Santo: 10 lead-sponsored trials and 0 legal-entity registrations.

Get the Universidad de Especialidades Espiritu Santo report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (12)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Stroke 3
Alveolar Bone Loss 2
Bone Resorption 2
Cognitive Dysfunction 2
Atherosclerosis 1

Showing 5 of 12 disease areas.

Start your 14-day trial Email me all 12 disease areas as a PDF

Trials by start year as sponsor or collaborator (6)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 3
2025 3
2024 3
2019 2
2014 1
2012 1

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Journals published in (18)

Shown in this order: most published in first.

Journals published in
Journal Publications
Sleep 3
International journal of geriatric psychiatry 2
Journal of community health 2
BMC oral health 1
BMC public health 1

Showing 5 of 18 journals.

Start your 14-day trial Email me all 18 journals as a PDF

FDA import refusals (1)

FDA import refusals
Refused import lines Latest refusal
1 2024-02-20

Organization relationships (1)

Organization relationships
Related organization Relationship Evidence
Respiralab Co sponsors trial with 1

Latest dated events (14)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-06-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 14 events.

Start your 14-day trial Email me all 14 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.